Clinical Trial Update: A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on MGV354 in ocular hypertension and open-angle glaucoma across Phase 1 and Phase 2. The results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• MGV354

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-31